<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="Research Article" dtd-version="1.0"><front><journal-meta><journal-id journal-id-type="pmc">iarjms</journal-id><journal-id journal-id-type="pubmed">IARJMS</journal-id><journal-id journal-id-type="publisher">IARJMS</journal-id><issn>2708-3594</issn></journal-meta><article-meta><article-id pub-id-type="doi">https://doi.org/10.47310/iarjms.2021.v02i01.017</article-id><title-group><article-title>Supervision of Antibiotics Switch from Intravenous to Per Oral and its Added Benefits for Better Patient Compliance</article-title></title-group><contrib-group><contrib contrib-type="author"><name><given-names>SM</given-names><surname>Biradar</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Chaitanya</given-names><surname>kulkarni</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Kanagala</given-names><surname>Srikanth</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>SachinL</given-names><surname>Kanakappanavar</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>BS Khaja</given-names><surname>Jainuddin</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>SS.</given-names><surname>Devarmani</surname></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><given-names>Sharan</given-names><surname>Badiger</surname></name></contrib></contrib-group><aff-id id="aff-a" /><abstract>Introduction: Antibiotics Intra Venus (IV) to per oral (PO) conversion is one of the key strategies in the antimicrobial stewardship program (ASP).&amp;nbsp;Early switch over from IV to oral therapy has major advantages, such as reduced risk of catheter related infections, less expensive, reduction in the hidden costs and early discharge from a hospital. Materials and Methods: A prospective and observational study was conducted over a period of six month among respiratory tract infection patients who admitted to general medicine and pulmonary department. The necessary data were collected in specially designed format from respective case sheets. Results: 84 patients were enrolled in the present study and 71 patients were subjected to antibiotic conversion whereas 13 patients were not subjected to antibiotic conversion. The patients who were subjected to antibiotic conversion were divided into 2 groups, Group E and Group L. Group E had subjects who were converted early from IV to oral antibiotic within 1-4 days and Group L had subjects who were converted from IV to oral antibiotics within 5-10 days. Out of 71 patients, 39 patients were subjected to early antibiotic switch whereas 32 patients were subjected to late antibiotic switch. The frequently prescribed IV antibiotic was levofloxacin (39.02%) and same is switched to oral (39.1%). The most common type of antibiotic conversion method was step down therapy (68%) and the most frequently converted class of antibiotics was fluoroquinolones. Conclusion: conversion of antibiotics from IV to per oral, especially early conversion reduce the length of hospital stay and reduce the financial burden of a patients and, minimizes the possible IV complications which influence the faster recovery of a patients and improves the better patient compliance.</abstract></article-meta></front><body /><back /></article>